{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-trigeminal","title":"PT-141 for Trigeminal: Evidence Review","body":"## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\n\n## What people say on Reddit\n\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\n\n## What people say on X\n\nNo posts identified connecting PT-141 use to trigeminal neuralgia or related pain.\n\n## What we do not know\n\nDirect evidence for PT-141 in trigeminal degeneration layers remains absent. Any overlap with CNS arousal pathways or intranasal delivery routes (which can involve trigeminal nerves for CNS access) is mechanistic only and untested for this use.\n\n## Safety and limits\n\nPT-141 carries known side effects in its approved context, including nausea and blood pressure changes. Application to trigeminal concerns lacks safety data. All discussion stays within repair-versus-degeneration framing without implying treatment.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-trigeminal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the core mechanism referenced in the peptide chain.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Confirms absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.","section":"What we do not know","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Notes the only trigeminal-related mechanistic link found.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","summary":"Describes PT-141 central melanocortin action for sexual response.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","summary":"Approved use limited to HSDD; no trigeminal mention.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"http_403","quote_status":"unverified","prev":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474","hash":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972"},{"id":"s3","type":"other","url":"https://palmettopeptides.com/blogs/news/pt-141-vs-mt-2-melanocortin-research-comparison","title":"PT-141 vs MT-2 Melanocortin Research Comparison","quote":"The intranasal route is particularly relevant for CNS-targeted research with these compounds, as it facilitates delivery via the olfactory and trigeminal nerve pathways to the CNS","summary":"Mechanistic note on trigeminal involvement in delivery only.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"http_526","quote_status":"unverified","prev":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972","hash":"32e645dc3950a0fe817a8e785d4baa27953a23cf12e2c27c7fb71248d34f1da3"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:05:58.499Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Trigeminal: Evidence Review","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\n\n## What people say on Reddit\n\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\n\n## What people say on X\n\nNo posts identified connecting PT-141 use to trigeminal neuralgia or related pain.\n\n## What we do not know\n\nDirect evidence for PT-141 in trigeminal degeneration layers remains absent. Any overlap with CNS arousal pathways or intranasal delivery routes (which can involve trigeminal nerves for CNS access) is mechanistic only and untested for this use.\n\n## Safety and limits\n\nPT-141 carries known side effects in its approved context, including nausea and blood pressure changes. Application to trigeminal concerns lacks safety data. All discussion stays within repair-versus-degeneration framing without implying treatment.","claims":[{"id":"c1","text":"PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the core mechanism referenced in the peptide chain.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Confirms absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.","section":"What we do not know","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Notes the only trigeminal-related mechanistic link found.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","link_status":"http_403","quote_status":"unverified"},{"id":"s3","type":"other","url":"https://palmettopeptides.com/blogs/news/pt-141-vs-mt-2-melanocortin-research-comparison","title":"PT-141 vs MT-2 Melanocortin Research Comparison","quote":"The intranasal route is particularly relevant for CNS-targeted research with these compounds, as it facilitates delivery via the olfactory and trigeminal nerve pathways to the CNS","link_status":"http_526","quote_status":"unverified"}]},"rationale":"","tokens_in":12579,"tokens_out":2447,"cost":0.02184125,"prev_hash":"genesis","hash":"8dd9f01b7bcc94f4234a5d80a497e5005cf2b2083e75cd424456a6993152ff2d"}],"provenance":[{"ts":"2026-06-30T01:05:58.499Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Trigeminal\nSlug: pt-141-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from pep","response":"{\n  \"slug\": \"pt-141-trigeminal\",\n  \"title\": \"PT-141 for Trigeminal: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\\n\\n## Why PT-141 might help you\\n\\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\\n\\n## What the evidence actually shows\\n\\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\\n\\n## What scientists say\\n\\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\\n\\n## What people say on Reddit\\n\\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\\n\\n## What peopl","tokens_in":12579,"tokens_out":2447,"cost":0,"prev":"genesis","hash":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e"},{"ts":"2026-07-17T02:41:12.325Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-trigeminal","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e","hash":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"}],"energy":{"passes":2,"tokens_in":12579,"tokens_out":2447,"tokens_total":15026,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"},"posted_at":"2026-06-29T21:32:56.501Z","created_at":"2026-06-29T21:32:56.501Z","updated_at":"2026-07-17T02:41:12.325Z","machine":{"shape":"article.machine/v1","slug":"pt-141-trigeminal","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-trigeminal","json":"https://miscsubjects.com/api/articles/pt-141-trigeminal","bundle":"https://miscsubjects.com/api/articles/pt-141-trigeminal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-trigeminal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-trigeminal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-trigeminal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-trigeminal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-trigeminal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-trigeminal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-trigeminal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-trigeminal","json":"/api/articles/pt-141-trigeminal","markdown":"/api/articles/pt-141-trigeminal/bundle?format=markdown","skill":"/api/articles/pt-141-trigeminal/skill","topology":"/api/articles/pt-141-trigeminal/topology","versions":"/api/articles/pt-141-trigeminal/revisions","invocations":"/api/articles/pt-141-trigeminal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-trigeminal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"6e81c9ef37c85a7687db884e0331e1e9d08bcfe5b70fcbf07b8b01abd466be97","object":{"object_type":"article-object","identity":{"id":"article:pt-141-trigeminal","slug":"pt-141-trigeminal","title":"PT-141 for Trigeminal: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-trigeminal","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-trigeminal/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-trigeminal\ndescription: Apply the PT-141 for Trigeminal: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Trigeminal: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-trigeminal). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-trigeminal.\n- Read claims and relationships at /api/articles/pt-141-trigeminal/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Trigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signa\n\n## Representations\n\n- Human: /a/pt-141-trigeminal\n- JSON: /api/articles/pt-141-trigeminal\n- Relationships: /api/articles/pt-141-trigeminal/topology\n- History: /api/articles/pt-141-trigeminal/revisions\n"},"json":{"route":"/api/articles/pt-141-trigeminal","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-trigeminal/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","trigeminal"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-trigeminal/invocations?status=success","failure_events":"/api/articles/pt-141-trigeminal/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-trigeminal","title":"PT-141 for Trigeminal: Evidence Review","body":"## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\n\n## What people say on Reddit\n\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\n\n## What people say on X\n\nNo posts identified connecting PT-141 use to trigeminal neuralgia or related pain.\n\n## What we do not know\n\nDirect evidence for PT-141 in trigeminal degeneration layers remains absent. Any overlap with CNS arousal pathways or intranasal delivery routes (which can involve trigeminal nerves for CNS access) is mechanistic only and untested for this use.\n\n## Safety and limits\n\nPT-141 carries known side effects in its approved context, including nausea and blood pressure changes. Application to trigeminal concerns lacks safety data. All discussion stays within repair-versus-degeneration framing without implying treatment.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-trigeminal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the core mechanism referenced in the peptide chain.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Confirms absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.","section":"What we do not know","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Notes the only trigeminal-related mechanistic link found.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","summary":"Describes PT-141 central melanocortin action for sexual response.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","summary":"Approved use limited to HSDD; no trigeminal mention.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"http_403","quote_status":"unverified","prev":"38a341bdef183a029fa322f24898518fb03557981be3c7b90fa610175215a474","hash":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972"},{"id":"s3","type":"other","url":"https://palmettopeptides.com/blogs/news/pt-141-vs-mt-2-melanocortin-research-comparison","title":"PT-141 vs MT-2 Melanocortin Research Comparison","quote":"The intranasal route is particularly relevant for CNS-targeted research with these compounds, as it facilitates delivery via the olfactory and trigeminal nerve pathways to the CNS","summary":"Mechanistic note on trigeminal involvement in delivery only.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:05:57.869Z","link_status":"http_526","quote_status":"unverified","prev":"c1b7a3cf80b240d3a1fa90007cf108d908349100c899c086129c04c1e4d9e972","hash":"32e645dc3950a0fe817a8e785d4baa27953a23cf12e2c27c7fb71248d34f1da3"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:05:58.499Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Trigeminal: Evidence Review","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\n\n## What people say on Reddit\n\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\n\n## What people say on X\n\nNo posts identified connecting PT-141 use to trigeminal neuralgia or related pain.\n\n## What we do not know\n\nDirect evidence for PT-141 in trigeminal degeneration layers remains absent. Any overlap with CNS arousal pathways or intranasal delivery routes (which can involve trigeminal nerves for CNS access) is mechanistic only and untested for this use.\n\n## Safety and limits\n\nPT-141 carries known side effects in its approved context, including nausea and blood pressure changes. Application to trigeminal concerns lacks safety data. All discussion stays within repair-versus-degeneration framing without implying treatment.","claims":[{"id":"c1","text":"PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the core mechanism referenced in the peptide chain.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Confirms absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.","section":"What we do not know","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Notes the only trigeminal-related mechanistic link found.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:05:58.014Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/","title":"Melanocortin Receptors, Melanotropic Peptides and Penile Erection","quote":"With its central mechanism of action, PT-141 may act independent or synergistically with PDE-5 inhibitors","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"review","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD)","link_status":"http_403","quote_status":"unverified"},{"id":"s3","type":"other","url":"https://palmettopeptides.com/blogs/news/pt-141-vs-mt-2-melanocortin-research-comparison","title":"PT-141 vs MT-2 Melanocortin Research Comparison","quote":"The intranasal route is particularly relevant for CNS-targeted research with these compounds, as it facilitates delivery via the olfactory and trigeminal nerve pathways to the CNS","link_status":"http_526","quote_status":"unverified"}]},"rationale":"","tokens_in":12579,"tokens_out":2447,"cost":0.02184125,"prev_hash":"genesis","hash":"8dd9f01b7bcc94f4234a5d80a497e5005cf2b2083e75cd424456a6993152ff2d"}],"provenance":[{"ts":"2026-06-30T01:05:58.499Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Trigeminal\nSlug: pt-141-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from pep","response":"{\n  \"slug\": \"pt-141-trigeminal\",\n  \"title\": \"PT-141 for Trigeminal: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\\n\\n## Why PT-141 might help you\\n\\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\\n\\n## What the evidence actually shows\\n\\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\\n\\n## What scientists say\\n\\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\\n\\n## What people say on Reddit\\n\\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\\n\\n## What peopl","tokens_in":12579,"tokens_out":2447,"cost":0,"prev":"genesis","hash":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e"},{"ts":"2026-07-17T02:41:12.325Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-trigeminal","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e","hash":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"}],"energy":{"passes":2,"tokens_in":12579,"tokens_out":2447,"tokens_total":15026,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"},"posted_at":"2026-06-29T21:32:56.501Z","created_at":"2026-06-29T21:32:56.501Z","updated_at":"2026-07-17T02:41:12.325Z","machine":{"shape":"article.machine/v1","slug":"pt-141-trigeminal","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-trigeminal","json":"https://miscsubjects.com/api/articles/pt-141-trigeminal","bundle":"https://miscsubjects.com/api/articles/pt-141-trigeminal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-trigeminal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-trigeminal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-trigeminal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-trigeminal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-trigeminal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-trigeminal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-trigeminal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-trigeminal","json":"/api/articles/pt-141-trigeminal","markdown":"/api/articles/pt-141-trigeminal/bundle?format=markdown","skill":"/api/articles/pt-141-trigeminal/skill","topology":"/api/articles/pt-141-trigeminal/topology","versions":"/api/articles/pt-141-trigeminal/revisions","invocations":"/api/articles/pt-141-trigeminal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-trigeminal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"6e81c9ef37c85a7687db884e0331e1e9d08bcfe5b70fcbf07b8b01abd466be97"}}}